Speech-Language Pathologists in Leonia, NJ Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Victoria Michelle Galfo, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 139 Vreeland Ave, Leonia, NJ 07605 Phone: 201-592-0054 |
Janet Wehrle, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 346 Sylvan Ave, Leonia, NJ 07605 Phone: 201-972-5280 |
Helena Nussbaum, M.A CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 84 Meadowview Ct, Leonia, NJ 07605 Phone: 201-388-7464 |
Valerie Massrock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202b Glenwood Ave, Apt 2e, Leonia, NJ 07605 Phone: 845-597-6414 |
News Archive
A backbone free energy study of SARS-CoV-2 variants of concern
A recent study by scientist Robert Penner at the Institut des Hautes Études Scientifiques in France utilizes free energy calculations to predict effective antiviral targets that are highly conserved, surface-accessible for interaction, and resistant to mutation.
Americans willing to pay more, but up to a limit, for safer food
Government regulators could more realistically assess the value of improving food safety if they considered the fact that consumers typically want to avoid getting sick - even if it means they have to pay a little extra for safer food, researchers say.
Boehringer Ingelheim to announce positive results from its RE-COVER study
Boehringer Ingelheim will announce positive results from the landmark RE-COVER™ study at the 51st Annual Meeting of the American Society of Hematology on 6 December 2009. The RE-COVER™ study assessed dabigatran etexilate in a head-to-head comparison with the current standard in care, warfarin, for the treatment of acute venous thromboembolism (VTE), enabling healthcare professionals to make direct comparisons and care based value judgements.
Viewpoints: 9 'brilliant legal minds' wrestle with tough biological questions in gene case; Drug overdoses take surprising toll in Calif.; VA case raises privacy questions
When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes cuts both ways, leading to a potential split among the justices (Jon Healey, 4/15).
› Verified 9 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors